Sysmex

Covid-19 divides the biggest medtechs

Success or failure on the stock markets this year depended almost entirely on whether a company’s devices could be used to treat coronavirus patients.

Few groups have developed Covid-19 diagnostics – but this will change

The FDA is loosening its rules on the authorisation of diagnostic tests for the new coronavirus, but it is still some way behind Europe.

January 14, 2019

Led by Tandem, small-cap medtechs pump up the value in 2018

The fastest share price growth in medtech is always recorded by small-caps, but Tandem reached a new extreme last year.

July 04, 2017

Startling reversal of fortunes as large-cap medtechs soar

July 08, 2015

Innovation ever more important for mid- and small-cap companies

January 15, 2015

Mid-cap medtech shares rise in 2014 on deals and the possibility of more

November 05, 2014

The next medtech megamerger?

July 10, 2014

Smaller companies swirl in the wake of medtech megamergers

June 02, 2014

Asco – Academia gives Erbitux another chance to gain share in colorectal cancer

January 13, 2014

Biotech exuberance spills over to big medtech

July 17, 2013

Large-cap medtech rises driven by smart buys and new tech